Articles
-
4 days ago |
insights.citeline.com | Ashley Yeo
UK Medtech Regulators Must Ensure Certainty So Businesses Can Plan Their FuturesInnovators Still Await The Broad-Scale Adoption System Ecosystem That Rewards ResearchWith medtech businesses typically managing investment cycles on a three- to five-year basis, local regulatory processes and forward costs of market entry must offer an attractive environment in which companies can plan for growth, says McDermott Will and Emery’s partner and head of healthcare and life sciences, Sharon Lamb.
-
5 days ago |
insights.citeline.com | Ashley Yeo
Will NICE’s New Medtech Evaluation Plans Hit the Target for Patients and Industry? Concern That Rules-Based Pathway As Currently Proposed Is Too Limited To Secure Much-Needed ChangeOne year after the UK mooted the Rules-Based Pathway to give medtechs clarity on what can be expected from an evaluation, the devices industry says UK healthtech assessment and adoption processes are still failing to meet the needs of innovators and patients.
-
2 weeks ago |
insights.citeline.com | Ashley Yeo
Rising Leaders 2025: Christina Ziegenberg On Keeping Medtechs Competitive And MDR Compliant BVMed’s Regulatory Chief Is Increasingly Required To Represent Industry At Political Level Good medical device regulation brings balance and builds bridges between healthcare stakeholders. It also accords equal priority to innovation and patient safety. A zero-risk policy cannot achieve these goals, says Christina Ziegenberg, BVMed’s head of regulatory affairs of six years.
-
3 weeks ago |
insights.citeline.com | Ashley Yeo
UK Must Put Adoption On A Par With Innovation, AZ Tells BioWales Forum Industry-Provider Collaborations And Partnerships More Valid Than EverMarket access concerns dominated at the annual BioWales In London event, where AstraZeneca set out industry’s priorities and the UK Office for Life Sciences struck an optimistic tone about how the UK will lastingly improve uptake of innovation.
-
1 month ago |
insights.citeline.com | Ashley Yeo
Three Steps To Investor Heaven For Founders: Articulate, Explain, Clarify UK Panel Says No Shortage Of Financing For The Right TechnologiesCapital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 149
- Tweets
- 267
- DMs Open
- No
RT @tobylitt: Zadie Smith 🔥🔥🔥 for @XrRebel "..the lobbyists of Tufton Street are deeply aggravated to discover their plans to double thei…
Germany's 2023 hospital reform and DRG payment changes, hybrid DRGs and more explained in Medtech Insight's @Medtech_Insight podcast with Germany Trade & Invest's Gabriel Flemming. https://t.co/ORndH2rY82
RT @tom_watson: I’ve been thinking about this a lot. Binley mega chippy needs a sign.